<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39287023</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>17</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1949-0984</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Season>Jan-Dec</Season></PubDate></JournalIssue><Title>Gut microbes</Title><ISOAbbreviation>Gut Microbes</ISOAbbreviation></Journal><ArticleTitle>Gut microbe-host interactions in post-COVID syndrome: a debilitating or restorative partnership?</ArticleTitle><Pagination><StartPage>2402544</StartPage><MedlinePgn>2402544</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2402544</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1080/19490976.2024.2402544</ELocationID><Abstract><AbstractText>Post-COVID syndrome (PCS) patients have reported a wide range of symptoms, including fatigue, shortness of breath, and diarrhea. Particularly, the presence of gastrointestinal symptoms has led to the hypothesis that the gut microbiome is involved in the development and severity of PCS. The objective of this review is to provide an overview of the role of the gut microbiome in PCS by describing the microbial composition and microbial metabolites in COVID-19 and PCS. Moreover, host-microbe interactions via the microbiota-gut-brain (MGB) and the microbiota-gut-lung (MGL) axes are described. Furthermore, we explore the potential of therapeutically targeting the gut microbiome to support the recovery of PCS by reviewing preclinical model systems and clinical studies. Overall, current studies provide evidence that the gut microbiota is affected in PCS; however, diversity in symptoms and highly individual microbiota compositions suggest the need for personalized medicine. Gut-targeted therapies, including treatments with pre- and probiotics, have the potential to improve the quality of life of affected individuals.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Scheithauer</LastName><ForeName>Torsten P M</ForeName><Initials>TPM</Initials><Identifier Source="ORCID">0000-0003-1446-3180</Identifier><AffiliationInfo><Affiliation>Department of Microbiology and Systems Biology, Netherlands Organisation for Applied Scientific Research (TNO), Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montijn</LastName><ForeName>Roy C</ForeName><Initials>RC</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Systems Biology, Netherlands Organisation for Applied Scientific Research (TNO), Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mieremet</LastName><ForeName>Arnout</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-8330-7491</Identifier><AffiliationInfo><Affiliation>Department of Microbiology and Systems Biology, Netherlands Organisation for Applied Scientific Research (TNO), Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Gut Microbes</MedlineTA><NlmUniqueID>101495343</NlmUniqueID><ISSNLinking>1949-0976</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069196" MajorTopicYN="Y">Gastrointestinal Microbiome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000076662" MajorTopicYN="Y">Host Microbial Interactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019936" MajorTopicYN="Y">Probiotics</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000087502" MajorTopicYN="N">Brain-Gut Axis</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064806" MajorTopicYN="N">Dysbiosis</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Gut microbiome</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">post-acute COVID-19 syndrome</Keyword></KeywordList><CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>17</Day><Hour>21</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>17</Day><Hour>21</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>17</Day><Hour>6</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39287023</ArticleId><ArticleId IdType="pmc">PMC11409505</ArticleId><ArticleId IdType="doi">10.1080/19490976.2024.2402544</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Su S, Zhao Y, Zeng N, Liu X, Zheng Y, Sun J, Zhong Y, Wu S, Ni S, Gong Y, et al. Epidemiology, clinical presentation, pathophysiology, and management of long COVID: an update. Mol Psychiatry. 2023;28(10):4056&#x2013;20. doi:10.1038/s41380-023-02171-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-023-02171-3</ArticleId><ArticleId IdType="pubmed">37491461</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV.. A clinical case definition of post-COVID-19 condition by a delphi consensus. The Lancet Infect Dis. 2022;22(4):e102&#x2013;e7. doi:10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133&#x2013;146. doi:10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran VT, Porcher R, Pane I, Ravaud P. Course of post COVID-19 disease symptoms over time in the ComPaRe long COVID prospective e-cohort. Nat Commun. 2022;13(1):1812. doi:10.1038/s41467-022-29513-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29513-z</ArticleId><ArticleId IdType="pmc">PMC8983754</ArticleId><ArticleId IdType="pubmed">35383197</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampshire A, Azor A, Atchison C, Trender W, Hellyer PJ, Giunchiglia V, Husain M, Cooke GS, Cooper E, Lound A, et al. Cognition and memory after COVID-19 in a large community sample. N Engl J Med. 2024;390(9):806&#x2013;818. doi:10.1056/NEJMoa2311330.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2311330</ArticleId><ArticleId IdType="pmc">PMC7615803</ArticleId><ArticleId IdType="pubmed">38416429</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xf6;ller M, Borg K, Janson C, Lerm M, Normark J, Niward K. Cognitive dysfunction in post-COVID-19 condition: mechanisms, management, and rehabilitation. J Intern Med. 2023;294(5):563&#x2013;581. doi:10.1111/joim.13720.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13720</ArticleId><ArticleId IdType="pubmed">37766515</ArticleId></ArticleIdList></Reference><Reference><Citation>Choudhury A, Tariq R, Jena A, Vesely EK, Singh S, Khanna S, Sharma V. Gastrointestinal manifestations of long COVID: a systematic review and meta-analysis. Therap Adv Gastroenterol. 2022;15:17562848221118403. doi:10.1177/17562848221118403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/17562848221118403</ArticleId><ArticleId IdType="pmc">PMC9393939</ArticleId><ArticleId IdType="pubmed">36004306</ArticleId></ArticleIdList></Reference><Reference><Citation>Ancona G, Alagna L, Alteri C, Palomba E, Tonizzo A, Pastena A, Muscatello A, Gori A, Bandera A. Gut and airway microbiota dysbiosis and their role in COVID-19 and long-covid. Front Immunol. 2023;14:1080043. doi:10.3389/fimmu.2023.1080043.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1080043</ArticleId><ArticleId IdType="pmc">PMC10030519</ArticleId><ArticleId IdType="pubmed">36969243</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang C, Lin H. Dysbiosis in gastrointestinal disorders. Best Pract Res Clin Gastroenterol. 2016;30(1):3&#x2013;15. doi:10.1016/j.bpg.2016.02.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpg.2016.02.001</ArticleId><ArticleId IdType="pubmed">27048892</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei L, Singh R, Ro S, Ghoshal UC. Gut microbiota dysbiosis in functional gastrointestinal disorders: underpinning the symptoms and pathophysiology. JGH Open. 2021;5(9):976&#x2013;987. doi:10.1002/jgh3.12528.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jgh3.12528</ArticleId><ArticleId IdType="pmc">PMC8454481</ArticleId><ArticleId IdType="pubmed">34584964</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Q, Lau RI, Liu Q, Li MKT, Yan Mak JW, Lu W, Lau, IS, Lau, LH, Yeung, GT, Cheung, CP, Tang, W, et al. The gut microbiome associates with phenotypic manifestations of post-acute COVID-19 syndrome. Cell Host &amp; Microbe. 2024;32(5):651&#xad;&#x2013;660.e4. doi:10.1016/j.chom.2024.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2024.04.005</ArticleId><ArticleId IdType="pubmed">38657605</ArticleId></ArticleIdList></Reference><Reference><Citation>Berg G, Rybakova D, Fischer D, Cernava T, Verg&#xe8;s M-C, Charles T, Chen X, Cocolin L, Eversole K, Corral GH, et al. Microbiome definition re-visited: old concepts and new challenges. Microbiome. 2020;8(1):103. doi:10.1186/s40168-020-00875-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-020-00875-0</ArticleId><ArticleId IdType="pmc">PMC7329523</ArticleId><ArticleId IdType="pubmed">32605663</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh TS, Shanahan F, O&#x2019;Toole PW. The gut microbiome as a modulator of healthy ageing. Nat Rev Gastroenterol Hepatol. 2022;19(9):565&#x2013;584. doi:10.1038/s41575-022-00605-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41575-022-00605-x</ArticleId><ArticleId IdType="pmc">PMC9035980</ArticleId><ArticleId IdType="pubmed">35468952</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, Zhernakova DV, Kurilshikov A, Andreu-S&#xe1;nchez S, Wang D, Augustijn HE, Vich Vila A, Weersma RK, Medema MH, Netea MG, et al. Influence of the microbiome, diet and genetics on inter-individual variation in the human plasma metabolome. Nat Med. 2022;28(11):2333&#x2013;2343. doi:10.1038/s41591-022-02014-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02014-8</ArticleId><ArticleId IdType="pmc">PMC9671809</ArticleId><ArticleId IdType="pubmed">36216932</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou K, Wu ZX, Chen XY, Wang JQ, Zhang D, Xiao C, Zhu D, Koya JB, Wei L, Li J, et al. Microbiota in health and diseases. Sig Transduct Target Ther. 2022;7(1):135. doi:10.1038/s41392-022-00974-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-00974-4</ArticleId><ArticleId IdType="pmc">PMC9034083</ArticleId><ArticleId IdType="pubmed">35461318</ArticleId></ArticleIdList></Reference><Reference><Citation>Cipelli M, da Silva EM, C&#xe2;mara NOS, da Silva EM. Gut microbiota resilience mechanisms against pathogen infection and its role in inflammatory bowel disease. Curr Clin Micro Rpt. 2023;10(4):187&#x2013;197. doi:10.1007/s40588-023-00207-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40588-023-00207-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Perler BK, Friedman ES, Wu GD. The role of the gut microbiota in the relationship between diet and human health. Annu Rev Physiol. 2023;85(1):449&#x2013;468. doi:10.1146/annurev-physiol-031522-092054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-physiol-031522-092054</ArticleId><ArticleId IdType="pubmed">36375468</ArticleId></ArticleIdList></Reference><Reference><Citation>Gacesa R, Kurilshikov A, Vich Vila A, Sinha T, Klaassen MAY, Bolte LA, Andreu-S&#xe1;nchez S, Chen L, Collij V, Hu S, et al. Environmental factors shaping the gut microbiome in a Dutch population. Nature. 2022;604(7907):732&#x2013;739. doi:10.1038/s41586-022-04567-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04567-7</ArticleId><ArticleId IdType="pubmed">35418674</ArticleId></ArticleIdList></Reference><Reference><Citation>Hrncir T. Gut Microbiota Dysbiosis: triggers, consequences, diagnostic and therapeutic options. Microorganisms. 2022;10(3):10. doi:10.3390/microorganisms10030578.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms10030578</ArticleId><ArticleId IdType="pmc">PMC8954387</ArticleId><ArticleId IdType="pubmed">35336153</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma T, Sirpu Natesh N, Pothuraju R, Batra SK, Rachagani S. Gut microbiota: a non-target victim of pesticide-induced toxicity. Gut Microbes. 2023;15(1):2187578. doi:10.1080/19490976.2023.2187578.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2023.2187578</ArticleId><ArticleId IdType="pmc">PMC10026936</ArticleId><ArticleId IdType="pubmed">36919486</ArticleId></ArticleIdList></Reference><Reference><Citation>Kozlov M. How does chronic stress harm the gut? New clues emerge. Nature. 2024;626(7997):20. doi:10.1038/d41586-024-00188-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-024-00188-4</ArticleId><ArticleId IdType="pubmed">38263310</ArticleId></ArticleIdList></Reference><Reference><Citation>Manor O, Dai CL, Kornilov SA, Smith B, Price ND, Lovejoy JC, Gibbons SM, Magis AT. Health and disease markers correlate with gut microbiome composition across thousands of people. Nat Commun. 2020;11(1):5206. doi:10.1038/s41467-020-18871-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-18871-1</ArticleId><ArticleId IdType="pmc">PMC7562722</ArticleId><ArticleId IdType="pubmed">33060586</ArticleId></ArticleIdList></Reference><Reference><Citation>He G, Cao Y, Ma H, Guo S, Xu W, Wang D, Chen Y, Wang H. Causal effects between gut microbiome and myalgic Encephalomyelitis/Chronic fatigue syndrome: a two-sample Mendelian randomization study. Front Microbiol. 2023;14:1190894. doi:10.3389/fmicb.2023.1190894.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2023.1190894</ArticleId><ArticleId IdType="pmc">PMC10359717</ArticleId><ArticleId IdType="pubmed">37485509</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao XH, Luo T, Shi Y, He ZC, Tang R, Zhang PP, Cai J, Zhou X-D, Jiang D-P, Fei X-C, et al. A cohort autopsy study defines COVID-19 systemic pathogenesis. Cell Res. 2021;31(8):836&#x2013;846. doi:10.1038/s41422-021-00523-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-021-00523-8</ArticleId><ArticleId IdType="pmc">PMC8208380</ArticleId><ArticleId IdType="pubmed">34135479</ArticleId></ArticleIdList></Reference><Reference><Citation>Clerbaux LA, Mayasich SA, Mu&#xf1;oz A, Soares H, Petrillo M, Albertini MC, Lanthier N, Grenga L, Amorim M-J. Gut as an alternative entry route for SARS-CoV-2: current evidence and uncertainties of productive enteric infection in COVID-19. J Clin Med. 2022;11(19):11. doi:10.3390/jcm11195691.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11195691</ArticleId><ArticleId IdType="pmc">PMC9573230</ArticleId><ArticleId IdType="pubmed">36233559</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding S, Liang TJ. Is SARS-CoV-2 also an enteric pathogen with potential fecal&#x2013;oral transmission? A COVID-19 virological and clinical review. Gastroenterology. 2020;159(1):53&#x2013;61. doi:10.1053/j.gastro.2020.04.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.04.052</ArticleId><ArticleId IdType="pmc">PMC7184994</ArticleId><ArticleId IdType="pubmed">32353371</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson CB, Farzan M, Chen B, Choe H. Mechanisms of SARS-CoV-2 entry into cells. Nat Rev Mol Cell Biol. 2022;23(1):3&#x2013;20. doi:10.1038/s41580-021-00418-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-021-00418-x</ArticleId><ArticleId IdType="pmc">PMC8491763</ArticleId><ArticleId IdType="pubmed">34611326</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B, Zhang L, Wang Y, Dai T, Qin Z, Zhou F, Zhang L. Alterations in microbiota of patients with COVID-19: potential mechanisms and therapeutic interventions. Sig Transduct Target Ther. 2022;7(1):143. doi:10.1038/s41392-022-00986-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-00986-0</ArticleId><ArticleId IdType="pmc">PMC9052735</ArticleId><ArticleId IdType="pubmed">35487886</ArticleId></ArticleIdList></Reference><Reference><Citation>Harmer D, Gilbert M, Borman R, Clark KL. Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme. FEBS Lett. 2002;532(1&#x2013;2):107&#x2013;110. doi:10.1016/S0014-5793(02)03640-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0014-5793(02)03640-2</ArticleId><ArticleId IdType="pubmed">12459472</ArticleId></ArticleIdList></Reference><Reference><Citation>Hikmet F, M&#xe9;ar L, &#xc5; E, Micke P, Uhl&#xe9;n M, Lindskog C. The protein expression profile of ACE2 in human tissues. Mol Syst Biol. 2020;16(7):e9610. doi:10.15252/msb.20209610.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/msb.20209610</ArticleId><ArticleId IdType="pmc">PMC7383091</ArticleId><ArticleId IdType="pubmed">32715618</ArticleId></ArticleIdList></Reference><Reference><Citation>Rokkas T. Gastrointestinal involvement in COVID-19: a systematic review and meta-analysis. Ann Gastroenterol. 2020;33:355. doi:10.20524/aog.2020.0506.</Citation><ArticleIdList><ArticleId IdType="doi">10.20524/aog.2020.0506</ArticleId><ArticleId IdType="pmc">PMC7315709</ArticleId><ArticleId IdType="pubmed">32624655</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurath MF, &#xdc;berla K, Ng SC. Gut as viral reservoir: lessons from gut viromes, HIV and COVID-19. Gut. 2021;70(9):1605&#x2013;1608. doi:10.1136/gutjnl-2021-324622.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-324622</ArticleId><ArticleId IdType="pubmed">33903146</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Shao B, Dang Q, Chen Z, Zhou Q, Luo H, Yuan W, Sun Z. Pathogenesis and mechanism of gastrointestinal infection with COVID-19. Front Immunol. 2021;12:674074. doi:10.3389/fimmu.2021.674074.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.674074</ArticleId><ArticleId IdType="pmc">PMC8631495</ArticleId><ArticleId IdType="pubmed">34858386</ArticleId></ArticleIdList></Reference><Reference><Citation>Sievers BL, Cheng MTK, Csiba K, Meng B, Gupta RK. SARS-CoV-2 and innate immunity: the good, the bad, and the &#x201c;goldilocks&#x201d;. Cell Mol Immunol. 2024;21(2):171&#x2013;183. doi:10.1038/s41423-023-01104-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-023-01104-y</ArticleId><ArticleId IdType="pmc">PMC10805730</ArticleId><ArticleId IdType="pubmed">37985854</ArticleId></ArticleIdList></Reference><Reference><Citation>van Eijk LE, Binkhorst M, Bourgonje AR, Offringa AK, Mulder DJ, Bos EM, van Eijk LE, Kolundzic N, Abdulle AE, van der Voort PH, et al. COVID-19: immunopathology, pathophysiological mechanisms, and treatment options. The J Pathol. 2021;254(4):307&#x2013;331. doi:10.1002/path.5642.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.5642</ArticleId><ArticleId IdType="pmc">PMC8013908</ArticleId><ArticleId IdType="pubmed">33586189</ArticleId></ArticleIdList></Reference><Reference><Citation>Primorac D, Vrdoljak K, Brlek P, Paveli&#x107; E, Molnar V, Mati&#x161;i&#x107; V, Erceg Ivko&#x161;i&#x107; I, Par&#x10d;ina M. Adaptive immune responses and immunity to SARS-CoV-2. Front Immunol. 2022;13. doi:10.3389/fimmu.2022.848582.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.848582</ArticleId><ArticleId IdType="pmc">PMC9114812</ArticleId><ArticleId IdType="pubmed">35603211</ArticleId></ArticleIdList></Reference><Reference><Citation>Britton GJ, Chen-Liaw A, Cossarini F, Livanos AE, Spindler MP, Plitt T, Eggers J, Mogno I, Gonzalez-Reiche AS, Siu S, et al. Limited intestinal inflammation despite diarrhea, fecal viral RNA and SARS-CoV-2-specific IgA in patients with acute COVID-19. Sci Rep. 2021;11(1):13308. doi:10.1038/s41598-021-92740-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-92740-9</ArticleId><ArticleId IdType="pmc">PMC8233421</ArticleId><ArticleId IdType="pubmed">34172783</ArticleId></ArticleIdList></Reference><Reference><Citation>Maynard CL, Elson CO, Hatton RD, Weaver CT. Reciprocal interactions of the intestinal microbiota and immune system. Nature. 2012;489(7415):231&#x2013;241. doi:10.1038/nature11551.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11551</ArticleId><ArticleId IdType="pmc">PMC4492337</ArticleId><ArticleId IdType="pubmed">22972296</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng D, Liwinski T, Elinav E. Interaction between microbiota and immunity in health and disease. Cell Res. 2020;30(6):492&#x2013;506. doi:10.1038/s41422-020-0332-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-020-0332-7</ArticleId><ArticleId IdType="pmc">PMC7264227</ArticleId><ArticleId IdType="pubmed">32433595</ArticleId></ArticleIdList></Reference><Reference><Citation>Belkaid Y, Hand Timothy W. Role of the microbiota in immunity and inflammation. Cell. 2014;157(1):121&#x2013;141. doi:10.1016/j.cell.2014.03.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2014.03.011</ArticleId><ArticleId IdType="pmc">PMC4056765</ArticleId><ArticleId IdType="pubmed">24679531</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim CH. Complex regulatory effects of gut microbial short-chain fatty acids on immune tolerance and autoimmunity. Cell Mol Immunol. 2023;20(4):341&#x2013;350. doi:10.1038/s41423-023-00987-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-023-00987-1</ArticleId><ArticleId IdType="pmc">PMC10066346</ArticleId><ArticleId IdType="pubmed">36854801</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F, Lau RI, Liu Q, Su Q, Chan FKL, Ng SC. Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications. Nat Rev Gastroenterol Hepatol. 2023;20(5):323&#x2013;337. doi:10.1038/s41575-022-00698-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41575-022-00698-4</ArticleId><ArticleId IdType="pmc">PMC9589856</ArticleId><ArticleId IdType="pubmed">36271144</ArticleId></ArticleIdList></Reference><Reference><Citation>Clerbaux L-A, Filipovska J, Mu&#xf1;oz A, Petrillo M, Coecke S, Amorim M-J, Grenga L. Mechanisms leading to Gut Dysbiosis in COVID-19: current evidence and uncertainties based on adverse outcome pathways. J Clin Med. 2022;11(18):5400. doi:10.3390/jcm11185400.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11185400</ArticleId><ArticleId IdType="pmc">PMC9505288</ArticleId><ArticleId IdType="pubmed">36143044</ArticleId></ArticleIdList></Reference><Reference><Citation>Breton J, Galmiche M, D&#xe9;chelotte P. Dysbiotic gut bacteria in obesity: an overview of the metabolic mechanisms and therapeutic perspectives of next-generation probiotics. Microorganisms. 2022;10(2):10. doi:10.3390/microorganisms10020452.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms10020452</ArticleId><ArticleId IdType="pmc">PMC8877435</ArticleId><ArticleId IdType="pubmed">35208906</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaikh SR, Beck MA, Alwarawrah Y, MacIver NJ. Emerging mechanisms of obesity-associated immune dysfunction. Nat Rev Endocrinol. 2024;20(3):136&#x2013;148. doi:10.1038/s41574-023-00932-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41574-023-00932-2</ArticleId><ArticleId IdType="pubmed">38129700</ArticleId></ArticleIdList></Reference><Reference><Citation>Russo A, Pisaturo M, Zollo V, Martini S, Maggi P, Numis FG, Gentile I, Sangiovanni N, Rossomando AM, Bianco V, et al. Obesity as a risk factor of severe outcome of COVID-19: a pair-matched 1: 2 case&#x2013;control study. J Clin Med. 2023;12(12):12. doi:10.3390/jcm12124055.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12124055</ArticleId><ArticleId IdType="pmc">PMC10298877</ArticleId><ArticleId IdType="pubmed">37373748</ArticleId></ArticleIdList></Reference><Reference><Citation>Piazzesi A, Pane S, Del Chierico F, Romani L, Campana A, Palma P, Putignani L. The pediatric gut bacteriome and virome in response to SARS-CoV-2 infection. Front Cell Infect Microbiol. 2024;14:1335450. doi:10.3389/fcimb.2024.1335450.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2024.1335450</ArticleId><ArticleId IdType="pmc">PMC10839054</ArticleId><ArticleId IdType="pubmed">38318164</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian Y, K-y Sun, T-q Meng, Ye Z, S-m Guo, Z-m Li, Xiong C-L, Yin Y, Li H-G, Zhou L-Q, et al. Gut microbiota may not be fully restored in recovered COVID-19 patients after 3-month recovery. Front Nutr. 2021;8:182. doi:10.3389/fnut.2021.638825.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2021.638825</ArticleId><ArticleId IdType="pmc">PMC8155354</ArticleId><ArticleId IdType="pubmed">34055851</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, Mak JWY, Su Q, Yeoh YK, Lui G-Y, Ng SSS, Zhang F, Li AYL, Lu W, Hui DSC, et al. Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut. 2022;71(3):544&#x2013;552. doi:10.1136/gutjnl-2021-325989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-325989</ArticleId><ArticleId IdType="pubmed">35082169</ArticleId></ArticleIdList></Reference><Reference><Citation>Nandi A, Pecetta S, Bloom DE. Global antibiotic use during the COVID-19 pandemic: analysis of pharmaceutical sales data from 71 countries, 2020&#x2013;2022. eClinicalMedicine 2023; 57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9900305</ArticleId><ArticleId IdType="pubmed">36776504</ArticleId></ArticleIdList></Reference><Reference><Citation>Blaser MJ. Antibiotic use and its consequences for the normal microbiome. Science. 2016;352(6285):544&#x2013;545. doi:10.1126/science.aad9358.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aad9358</ArticleId><ArticleId IdType="pmc">PMC4939477</ArticleId><ArticleId IdType="pubmed">27126037</ArticleId></ArticleIdList></Reference><Reference><Citation>Queen J, Zhang J, Sears CL. Oral antibiotic use and chronic disease: long-term health impact beyond antimicrobial resistance and clostridioides difficile. Gut Microbes. 2020;11(4):1092&#x2013;1103. doi:10.1080/19490976.2019.1706425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2019.1706425</ArticleId><ArticleId IdType="pmc">PMC7524332</ArticleId><ArticleId IdType="pubmed">32037950</ArticleId></ArticleIdList></Reference><Reference><Citation>Ianiro G, Tilg H, Gasbarrini A. Antibiotics as deep modulators of gut microbiota: between good and evil. Gut. 2016;65(11):1906&#x2013;1915. doi:10.1136/gutjnl-2016-312297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2016-312297</ArticleId><ArticleId IdType="pubmed">27531828</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y-T, Wong D, Ashcroft DM, Massey J, MacKenna B, Fisher L, Mehrkar A, Bacon SC, Hand K, Zhong X, et al. Repeated antibiotic exposure and risk of hospitalisation and death following COVID-19 infection (OpenSAFELY): a matched case&#x2013;control study. eClinicalmedicine. 2023;61:102064. doi:10.1016/j.eclinm.2023.102064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2023.102064</ArticleId><ArticleId IdType="pmc">PMC10388579</ArticleId><ArticleId IdType="pubmed">37528841</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzman-Esquivel J, Mendoza-Hernandez MA, Guzman-Solorzano HP, Sarmiento-Hernandez KA, Rodriguez-Sanchez IP, Martinez-Fierro ML, Paz-Michel BA, Murillo-Zamora E, Rojas-Larios F, Lugo-Trampe A, et al. Clinical characteristics in the acute phase of COVID-19 that predict long COVID: tachycardia, myalgias, severity, and use of antibiotics as main risk factors, while education and blood group B are protective. Healthcare (Basel). 2023;11(2):11. doi:10.3390/healthcare11020197.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare11020197</ArticleId><ArticleId IdType="pmc">PMC9858709</ArticleId><ArticleId IdType="pubmed">36673565</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang D, Zhou Y, Ma Y, Chen P, Tang J, Yang B, Li H, Liang M, Xue Y, Liu Y, et al. Gut microbiota dysbiosis correlates with long COVID-19 at one-year after discharge. J Korean Med Sci. 2023;38(15):e120. doi:10.3346/jkms.2023.38.e120.</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2023.38.e120</ArticleId><ArticleId IdType="pmc">PMC10111044</ArticleId><ArticleId IdType="pubmed">37069814</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang D, Weng S, Xia C, Ren Y, Liu Z, Xu Y, Yang X, Wu R, Peng L, Sun L, et al. Gastrointestinal symptoms of long COVID-19 related to the ectopic colonization of specific bacteria that move between the upper and lower alimentary tract and alterations in serum metabolites. BMC Med. 2023;21(1):264. doi:10.1186/s12916-023-02972-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-023-02972-x</ArticleId><ArticleId IdType="pmc">PMC10355065</ArticleId><ArticleId IdType="pubmed">37468867</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd6;sterdahl MF, Whiston R, Sudre CH, Asnicar F, Cheetham NJ, Blanco Miguez A, Bowyer V, Antonelli M, Snell O, dos Santos Canas L, et al. Metabolomic and gut microbiome profiles across the spectrum of community-based COVID and non-covid disease. Sci Rep. 2023;13(1):10407. doi:10.1038/s41598-023-34598-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-34598-7</ArticleId><ArticleId IdType="pmc">PMC10300098</ArticleId><ArticleId IdType="pubmed">37369825</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamrefors V, Kahn F, Holmqvist M, Carlson K, Varjus R, Gudjonsson A, Fedorowski A, Ohlsson B. Gut microbiota composition is altered in postural orthostatic tachycardia syndrome and post-acute COVID-19 syndrome. Sci Rep. 2024;14(1):3389. doi:10.1038/s41598-024-53784-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-024-53784-9</ArticleId><ArticleId IdType="pmc">PMC10858216</ArticleId><ArticleId IdType="pubmed">38336892</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H, Wang J, He T, Becker S, Zhang G, Li D, Ma X. Butyrate: a double-edged sword for health? Adv Nutr. 2018;9(1):21&#x2013;29. doi:10.1093/advances/nmx009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/advances/nmx009</ArticleId><ArticleId IdType="pmc">PMC6333934</ArticleId><ArticleId IdType="pubmed">29438462</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F, Aschenbrenner D, Yoo JY, Zuo T. The gut mycobiome in health, disease, and clinical applications in association with the gut bacterial microbiome assembly. Lancet Microbe. 2022;3(12):e969&#x2013;e83. doi:10.1016/S2666-5247(22)00203-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(22)00203-8</ArticleId><ArticleId IdType="pubmed">36182668</ArticleId></ArticleIdList></Reference><Reference><Citation>Botschuijver S, Roeselers G, Levin E, Jonkers DM, Welting O, Heinsbroek SEM, de Weerd HH, Boekhout T, Fornai M, Masclee AA, et al. Intestinal fungal dysbiosis is associated with visceral hypersensitivity in patients with irritable bowel syndrome and rats. Gastroenterology. 2017;153(4):1026&#x2013;1039. doi:10.1053/j.gastro.2017.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2017.06.004</ArticleId><ArticleId IdType="pubmed">28624575</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T, Zhan H, Zhang F, Liu Q, Tso EYK, Lui GCY, Chen N, Li A, Lu W, Chan FKL, et al. Alterations in fecal fungal microbiome of patients with COVID-19 during time of hospitalization until discharge. Gastroenterology. 2020;159(4):1302&#x2013;10.e5. doi:10.1053/j.gastro.2020.06.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.06.048</ArticleId><ArticleId IdType="pmc">PMC7318920</ArticleId><ArticleId IdType="pubmed">32598884</ArticleId></ArticleIdList></Reference><Reference><Citation>Kusakabe T, Lin WY, Cheong JG, Singh G, Ravishankar A, Yeung ST, Mesko M, DeCelie MB, Carriche G, Zhao Z, et al. Fungal microbiota sustains lasting immune activation of neutrophils and their progenitors in severe COVID-19. Nat Immunol. 2023;24(11):1879&#x2013;1889. doi:10.1038/s41590-023-01637-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-023-01637-4</ArticleId><ArticleId IdType="pmc">PMC10805066</ArticleId><ArticleId IdType="pubmed">37872315</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagree K, Chen P. Candida makes a lasting impression in COVID-19. Nat Immunol. 2023;24(11):1782&#x2013;1784. doi:10.1038/s41590-023-01648-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-023-01648-1</ArticleId><ArticleId IdType="pubmed">37872314</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C, Jiang ML, Jiang R, Pang T, Zhang CJ. The roles of fungus in CNS autoimmune and neurodegeneration disorders. Front Immunol. 2022;13:1077335. doi:10.3389/fimmu.2022.1077335.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1077335</ArticleId><ArticleId IdType="pmc">PMC9910218</ArticleId><ArticleId IdType="pubmed">36776399</ArticleId></ArticleIdList></Reference><Reference><Citation>Li N, Wang Q, Wang Y, Sun A, Lin Y, Jin Y, Li X. Fecal microbiota transplantation from chronic unpredictable mild stress mice donors affects anxiety-like and depression-like behavior in recipient mice via the gut microbiota-inflammation-brain axis. Stress. 2019;22(5):592&#x2013;602. doi:10.1080/10253890.2019.1617267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10253890.2019.1617267</ArticleId><ArticleId IdType="pubmed">31124390</ArticleId></ArticleIdList></Reference><Reference><Citation>de Almeida V M, Engel DF, Ricci MF, Cruz CS, Lopes &#xcd;S, Alves DA, d&#x2019; Auriol M, Magalh&#xe3;es J, Machado EC, Rocha VM, et al. Gut microbiota from patients with COVID-19 cause alterations in mice that resemble post-covid symptoms. Gut Microbes. 2023;15(2):2249146. doi:10.1080/19490976.2023.2249146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2023.2249146</ArticleId><ArticleId IdType="pmc">PMC10481883</ArticleId><ArticleId IdType="pubmed">37668317</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal AD, VanElzakker MB, Aleman S, Bach K, Boribong BP, Buggert M, Cherry S, Chertow DS, Davies HE, Dupont CL, et al. SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC). Nat Immunol. 2023;24(10):1616&#x2013;1627. doi:10.1038/s41590-023-01601-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-023-01601-2</ArticleId><ArticleId IdType="pubmed">37667052</ArticleId></ArticleIdList></Reference><Reference><Citation>Natarajan A, Zlitni S, Brooks EF, Vance SE, Dahlen A, Hedlin H, Park RM, Han A, Schmidtke DT, Verma R, et al. Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection. Med. 2022;3(6):371&#x2013;87.e9. doi:10.1016/j.medj.2022.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medj.2022.04.001</ArticleId><ArticleId IdType="pmc">PMC9005383</ArticleId><ArticleId IdType="pubmed">35434682</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivera-Cavazos A, Luviano-Garc&#xed;a JA, Garza-Silva A, Morales-Rodr&#xed;guez DP, Kuri-Ayache M, Sanz-S&#xe1;nchez M, Santos-Mac&#xed;as JE, Romero-Ibarguengoitia ME, Gonz&#xe1;lez-Cant&#xfa; A. Analyzing the interplay between COVID-19 viral load, inflammatory markers, and lymphocyte subpopulations on the development of long COVID. Microorganisms. 2023;11(9):11. doi:10.3390/microorganisms11092241.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms11092241</ArticleId><ArticleId IdType="pmc">PMC10536598</ArticleId><ArticleId IdType="pubmed">37764085</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia H, Cao Z, Xie X, Zhang X, Chen JY, Wang H, Menachery VD, Rajsbaum R, Shi P-Y. Evasion of type I interferon by SARS-CoV-2. Cell Rep. 2020;33(1):108234. doi:10.1016/j.celrep.2020.108234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.108234</ArticleId><ArticleId IdType="pmc">PMC7501843</ArticleId><ArticleId IdType="pubmed">32979938</ArticleId></ArticleIdList></Reference><Reference><Citation>Fakharian F, Thirugnanam S, Welsh DA, Kim W-K, Rappaport J, Bittinger K, Rout N. The role of gut dysbiosis in the loss of intestinal immune cell functions and viral pathogenesis. Microorganisms. 2023;11(7):1849. doi:10.3390/microorganisms11071849.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms11071849</ArticleId><ArticleId IdType="pmc">PMC10384393</ArticleId><ArticleId IdType="pubmed">37513022</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiorucci S, Urbani G, Biagioli M, Sepe V, Distrutti E, Zampella A. Bile acids and bile acid activated receptors in the treatment of COVID-19. Biochemical Pharmacol. 2023; 115983. doi:10.1016/j.bcp.2023.115983.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2023.115983</ArticleId><ArticleId IdType="pubmed">38081371</ArticleId></ArticleIdList></Reference><Reference><Citation>Harper A, Vijayakumar V, Ouwehand AC, Ter Haar J, Obis D, Espadaler J, Binda S, Desiraju S, Day R. Viral infections, the microbiome, and probiotics. Front Cell Infect Microbiol. 2020;10:596166. doi:10.3389/fcimb.2020.596166.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2020.596166</ArticleId><ArticleId IdType="pmc">PMC7907522</ArticleId><ArticleId IdType="pubmed">33643929</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeoh YK, Zuo T, Lui GC, Zhang F, Liu Q, Li AY, Chung AC, Cheung CP, Tso EY, Fung KS, et al. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut. 2021;70(4):698&#x2013;706. doi:10.1136/gutjnl-2020-323020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-323020</ArticleId><ArticleId IdType="pmc">PMC7804842</ArticleId><ArticleId IdType="pubmed">33431578</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T, Zhang F, Lui GCY, Yeoh YK, Li AYL, Zhan H, Wan Y, Chung ACK, Cheung CP, Chen N, et al. Alterations in gut microbiota of patients with COVID-19 during time of hospitalization. Gastroenterology. 2020;159(3):944&#x2013;55.e8. doi:10.1053/j.gastro.2020.05.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.05.048</ArticleId><ArticleId IdType="pmc">PMC7237927</ArticleId><ArticleId IdType="pubmed">32442562</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheithauer TPM, Davids M, Winkelmeijer M, Verdoes X, Aydin &#xd6;, de Brauw M, van de Laar A, Meijnikman AS, Gerdes VEA, van Raalte D, et al. Compensatory intestinal antibody response against pro-inflammatory microbiota after bariatric surgery. Gut Microbes. 2022;14(1):2031696. doi:10.1080/19490976.2022.2031696.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2022.2031696</ArticleId><ArticleId IdType="pmc">PMC8824225</ArticleId><ArticleId IdType="pubmed">35130127</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheithauer TPM, Bakker GJ, Winkelmeijer M, Davids M, Nieuwdorp M, van Raalte DH, Herrema H. Compensatory intestinal immunoglobulin response after vancomycin treatment in humans. Gut Microbes. 2021;13(1):1&#x2013;14. doi:10.1080/19490976.2021.1875109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2021.1875109</ArticleId><ArticleId IdType="pmc">PMC7833805</ArticleId><ArticleId IdType="pubmed">33475461</ArticleId></ArticleIdList></Reference><Reference><Citation>Postler TS, Ghosh S. Understanding the holobiont: how microbial metabolites affect human health and shape the immune system. Cell Metab. 2017;26(1):110&#x2013;130. doi:10.1016/j.cmet.2017.05.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2017.05.008</ArticleId><ArticleId IdType="pmc">PMC5535818</ArticleId><ArticleId IdType="pubmed">28625867</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Tan Y, Cheng H, Zhang D, Feng W, Peng C. Functions of gut microbiota metabolites, current status and future perspectives. Aging Dis. 2022;13(4):1106&#x2013;1126. doi:10.14336/AD.2022.0104.</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/AD.2022.0104</ArticleId><ArticleId IdType="pmc">PMC9286904</ArticleId><ArticleId IdType="pubmed">35855347</ArticleId></ArticleIdList></Reference><Reference><Citation>Donohoe DR, Garge N, Zhang X, Sun W, O&#x2019;Connell TM, Bunger MK, Bultman S. The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell Metab. 2011;13(5):517&#x2013;526. doi:10.1016/j.cmet.2011.02.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2011.02.018</ArticleId><ArticleId IdType="pmc">PMC3099420</ArticleId><ArticleId IdType="pubmed">21531334</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Hern&#xe1;ndez Y, Mon&#xe1;rrez-Espino J, L&#xf3;pez DAG, Zheng J, Borrego JC, Torres-Calzada C, Elizalde-D&#xed;az JP, Mandal R, Berjanskii M, Mart&#xed;nez-Mart&#xed;nez E, et al. The plasma metabolome of long COVID patients two years after infection. Sci Rep. 2023;13(1):12420. doi:10.1038/s41598-023-39049-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-39049-x</ArticleId><ArticleId IdType="pmc">PMC10394026</ArticleId><ArticleId IdType="pubmed">37528111</ArticleId></ArticleIdList></Reference><Reference><Citation>Lunjani N, Albrich WC, Suh N, Barda B, Finnegan LA, Dam SA, Walter J, Sadlier C, Horgan M, O&#x2019;Toole PW, et al. Higher levels of bacterial DNA in serum associate with severe and fatal COVID-19. Allergy. 2022;77(4):1312&#x2013;1314. doi:10.1111/all.15218.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.15218</ArticleId><ArticleId IdType="pmc">PMC9303653</ArticleId><ArticleId IdType="pubmed">35020222</ArticleId></ArticleIdList></Reference><Reference><Citation>Valentino MS, Esposito C, Colosimo S, Caprio AM, Puzone S, Guarino S, Marzuillo P, Miraglia Del Giudice E, Di Sessa A. Gut microbiota and COVID-19: an intriguing pediatric perspective. World J Clin Cases. 2022;10(23):8076&#x2013;8087. doi:10.12998/wjcc.v10.i23.8076.</Citation><ArticleIdList><ArticleId IdType="doi">10.12998/wjcc.v10.i23.8076</ArticleId><ArticleId IdType="pmc">PMC9403663</ArticleId><ArticleId IdType="pubmed">36159525</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadlier C, Albrich WC, Neogi U, Lunjani N, Horgan M, O&#x2019;Toole PW, O&#x2019;Mahony L. Metabolic rewiring and serotonin depletion in patients with postacute sequelae of COVID-19. Allergy. 2022;77(5):1623&#x2013;1625. doi:10.1111/all.15253.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.15253</ArticleId><ArticleId IdType="pmc">PMC9111264</ArticleId><ArticleId IdType="pubmed">35150456</ArticleId></ArticleIdList></Reference><Reference><Citation>Yano JM, Yu K, Donaldson GP, Shastri GG, Ann P, Ma L, Nagler C, Ismagilov R, Mazmanian S, Hsiao E, et al. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell. 2015;161(2):264&#x2013;276. doi:10.1016/j.cell.2015.02.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.02.047</ArticleId><ArticleId IdType="pmc">PMC4393509</ArticleId><ArticleId IdType="pubmed">25860609</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent AD, Wang XY, Parsons SP, Khan WI, Huizinga JD. Abnormal absorptive colonic motor activity in germ-free mice is rectified by butyrate, an effect possibly mediated by mucosal serotonin. Am J Physiol Gastrointest Liver Physiol. 2018;315(5):G896&#x2013;g907. doi:10.1152/ajpgi.00237.2017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpgi.00237.2017</ArticleId><ArticleId IdType="pubmed">30095295</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon YH, Khan WI. Peripheral serotonin: cultivating companionship with gut microbiota in intestinal homeostasis. Am J Physiol Cell Physiol. 2022;323(2):C550&#x2013;c5. doi:10.1152/ajpcell.00433.2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00433.2021</ArticleId><ArticleId IdType="pubmed">35759441</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F, Wan Y, Zuo T, Yeoh YK, Liu Q, Zhang L, Zhan H, Lu W, Xu W, Lui GCY, et al. Prolonged impairment of short-chain fatty acid and L-Isoleucine biosynthesis in gut microbiome in patients with COVID-19. Gastroenterology. 2022;162(2):548&#x2013;61.e4. doi:10.1053/j.gastro.2021.10.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2021.10.013</ArticleId><ArticleId IdType="pmc">PMC8529231</ArticleId><ArticleId IdType="pubmed">34687739</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv L, Jiang H, Chen Y, Gu S, Xia J, Zhang H, Lu Y, Yan R, Li L. The faecal metabolome in COVID-19 patients is altered and associated with clinical features and gut microbes. Anal Chim Acta. 2021;1152:338267. doi:10.1016/j.aca.2021.338267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aca.2021.338267</ArticleId><ArticleId IdType="pmc">PMC7847702</ArticleId><ArticleId IdType="pubmed">33648648</ArticleId></ArticleIdList></Reference><Reference><Citation>Stepanova N, Tolstanova G, Akulenko I, Savchenko S, Dobbynchuk T. Oxalate-degrading activity in fecal microbiota is associated with obesity and cardiovascular events in end-stage kidney disease patients. J Hypertens. 2023;41(Suppl 3):41. doi:10.1097/01.hjh.0000940212.27084.2c.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.hjh.0000940212.27084.2c</ArticleId></ArticleIdList></Reference><Reference><Citation>Cani PD. Gut microbiota &#x2014; at the intersection of everything? Nat Rev Gastroenterol Hepatol. 2017;14(6):321&#x2013;322. doi:10.1038/nrgastro.2017.54.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrgastro.2017.54</ArticleId><ArticleId IdType="pubmed">28442782</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei Y, Gao J, Kou Y, Liu M, Meng L, Zheng X, Xu S, Liang M, Sun H, Liu Z, et al. The intestinal microbial metabolite desaminotyrosine is an anti-inflammatory molecule that modulates local and systemic immune homeostasis. Faseb J. 2020;34(12):16117&#x2013;16128. doi:10.1096/fj.201902900RR.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201902900RR</ArticleId><ArticleId IdType="pubmed">33047367</ArticleId></ArticleIdList></Reference><Reference><Citation>Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol. 2009;9(5):313&#x2013;323. doi:10.1038/nri2515.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2515</ArticleId><ArticleId IdType="pmc">PMC4095778</ArticleId><ArticleId IdType="pubmed">19343057</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy EA, King KY, Baldridge MT. Mouse microbiota models: comparing germ-free mice and antibiotics treatment as tools for modifying gut bacteria. Front Physiol. 2018;9:1534. doi:10.3389/fphys.2018.01534.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2018.01534</ArticleId><ArticleId IdType="pmc">PMC6220354</ArticleId><ArticleId IdType="pubmed">30429801</ArticleId></ArticleIdList></Reference><Reference><Citation>Giron LB, Peluso MJ, Ding J, Kenny G, Zilberstein NF, Koshy J, Hong KY, Rasmussen H, Miller GE, Bishehsari F, et al. Markers of fungal translocation are elevated during post-acute sequelae of SARS-CoV-2 and induce nf-&#x3ba;B signaling. JCI Insight. 2022;7(18). doi:10.1172/jci.insight.164813.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.164813</ArticleId><ArticleId IdType="pmc">PMC9675436</ArticleId><ArticleId IdType="pubmed">36134654</ArticleId></ArticleIdList></Reference><Reference><Citation>Fasano A. Zonulin and Its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer. Physiol Rev. 2011;91(1):151&#x2013;175. doi:10.1152/physrev.00003.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00003.2008</ArticleId><ArticleId IdType="pubmed">21248165</ArticleId></ArticleIdList></Reference><Reference><Citation>Roth W, Zadeh K, Vekariya R, Ge Y, Mohamadzadeh M. Tryptophan metabolism and Gut-Brain Homeostasis. Int J Mol Sci. 2021;22(6):2973. doi:10.3390/ijms22062973.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22062973</ArticleId><ArticleId IdType="pmc">PMC8000752</ArticleId><ArticleId IdType="pubmed">33804088</ArticleId></ArticleIdList></Reference><Reference><Citation>Montazersaheb S, Hosseiniyan Khatibi SM, Hejazi MS, Tarhriz V, Farjami A, Ghasemian Sorbeni F, Farahzadi R, Ghasemnejad T. COVID-19 infection: an overview on cytokine storm and related interventions. Virol J. 2022;19(1):92. doi:10.1186/s12985-022-01814-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-022-01814-1</ArticleId><ArticleId IdType="pmc">PMC9134144</ArticleId><ArticleId IdType="pubmed">35619180</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, Darley DR, Wilson DB, Howe A, Munier CML, Patel SK, Juno JA, Burrell LM, Kent SJ, Dore GJ, et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. 2022;23(2):210&#x2013;216. doi:10.1038/s41590-021-01113-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan MG, Coffey JC, Sahebally SM, Tibbitts P, Lyons EM, O&#x2019;leary E, Owolabi F, Dunne CP.. Systemic molecular mediators of inflammation differentiate between Crohn&#x2019;s disease and ulcerative colitis, implicating threshold levels of IL-10 and relative ratios of pro-inflammatory cytokines in therapy. J Crohn&#x2019;s Colitis. 2019;14:118&#x2013;129. doi:10.1093/ecco-jcc/jjz117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ecco-jcc/jjz117</ArticleId><ArticleId IdType="pmc">PMC6930002</ArticleId><ArticleId IdType="pubmed">31241755</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh UP, Singh NP, Murphy EA, Price RL, Fayad R, Nagarkatti M, Nagarkatti, PS. Chemokine and cytokine levels in inflammatory bowel disease patients. Cytokine. 2016;77:44&#x2013;49. doi:10.1016/j.cyto.2015.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2015.10.008</ArticleId><ArticleId IdType="pmc">PMC4666758</ArticleId><ArticleId IdType="pubmed">26520877</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheithauer TPM, Rampanelli E, Nieuwdorp M, Vallance BA, Verchere CB, van Raalte DH, Herrema H. Gut microbiota as a trigger for metabolic inflammation in obesity and type 2 diabetes. Front Immunol. 2020;11:571731. doi:10.3389/fimmu.2020.571731.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.571731</ArticleId><ArticleId IdType="pmc">PMC7596417</ArticleId><ArticleId IdType="pubmed">33178196</ArticleId></ArticleIdList></Reference><Reference><Citation>Gareau MG, Barrett KE. Role of the microbiota-gut-brain axis in postacute COVID syndrome. Am J Physiol-Gastrointestinal Liver Physiol. 2023;324(4):G322&#x2013;G8. doi:10.1152/ajpgi.00293.2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpgi.00293.2022</ArticleId><ArticleId IdType="pmc">PMC10042594</ArticleId><ArticleId IdType="pubmed">36880667</ArticleId></ArticleIdList></Reference><Reference><Citation>Carloni S, Rescigno M. The gut-brain vascular axis in neuroinflammation. Semin Immunol. 2023;69:101802. doi:10.1016/j.smim.2023.101802.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.smim.2023.101802</ArticleId><ArticleId IdType="pubmed">37422929</ArticleId></ArticleIdList></Reference><Reference><Citation>Sajdel-Sulkowska EM, Amedei A. Neuropsychiatric ramifications of COVID-19: short-chain fatty acid deficiency and disturbance of microbiota-gut-brain axis signaling. Biomed Res Int. 2021;2021:1&#x2013;15. doi:10.1155/2021/7880448.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/7880448</ArticleId><ArticleId IdType="pmc">PMC8510788</ArticleId><ArticleId IdType="pubmed">34651049</ArticleId></ArticleIdList></Reference><Reference><Citation>Su X, Gao Y, Yang R. Gut microbiota-derived tryptophan metabolites maintain gut and systemic homeostasis. Cells. 2022;11(15):11. doi:10.3390/cells11152296.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11152296</ArticleId><ArticleId IdType="pmc">PMC9330295</ArticleId><ArticleId IdType="pubmed">35892593</ArticleId></ArticleIdList></Reference><Reference><Citation>Agus A, Planchais J, Sokol H. Gut microbiota regulation of tryptophan metabolism in health and disease. Cell Host &amp; Microbe. 2018;23(6):716&#x2013;724. doi:10.1016/j.chom.2018.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2018.05.003</ArticleId><ArticleId IdType="pubmed">29902437</ArticleId></ArticleIdList></Reference><Reference><Citation>Camargo Simone MR, Vuille-Dit-Bille Raphael N, Meier CF, Verrey F. ACE2 and gut amino acid transport. Clin Sci. 2020;134(21):2823&#x2013;2833. doi:10.1042/CS20200477.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20200477</ArticleId><ArticleId IdType="pubmed">33140827</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong AC, Devason AS, Umana IC, Cox TO, Dohnalov&#xe1; L, Litichevskiy L, Perla J, Lundgren P, Etwebi Z, Izzo LT, et al. Serotonin reduction in post-acute sequelae of viral infection. Cell. 2023;186(22):4851&#x2013;67.e20. doi:10.1016/j.cell.2023.09.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2023.09.013</ArticleId><ArticleId IdType="pmc">PMC11227373</ArticleId><ArticleId IdType="pubmed">37848036</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin WH, Liu CL, Jiang YH, Hu B, Wang HY, Fu J. Gut ACE2 expression, tryptophan deficiency, and inflammatory responses the potential connection that should not Be ignored during SARS-CoV-2 infection. Cellular And Mol Gastroenterol And Hepatol. 2021;12(4):1514&#x2013;6.e4. doi:10.1016/j.jcmgh.2021.06.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmgh.2021.06.014</ArticleId><ArticleId IdType="pmc">PMC8243630</ArticleId><ArticleId IdType="pubmed">34216827</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer D, Camargo SMR, Ramadan T, Sch&#xe4;fer M, Mariotta L, Herzog B, Huggel K, Wolfer D, Werner S, Penninger JM, et al. Defective intestinal amino acid absorption in Ace2 null mice. Am J Physiol-Gastrointestinal And Liver Physiol. 2012;303(6):G686&#x2013;G95. doi:10.1152/ajpgi.00140.2012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpgi.00140.2012</ArticleId><ArticleId IdType="pubmed">22790597</ArticleId></ArticleIdList></Reference><Reference><Citation>Klempin F, Mosienko V, Matthes S, Villela DC, Todiras M, Penninger JM, Bader M, Santos RAS, Alenina N. Depletion of angiotensin-converting enzyme 2 reduces brain serotonin and impairs the running-induced neurogenic response. Cell Mol Life Sci. 2018;75(19):3625&#x2013;3634. doi:10.1007/s00018-018-2815-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-018-2815-y</ArticleId><ArticleId IdType="pmc">PMC7079801</ArticleId><ArticleId IdType="pubmed">29679094</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Li HB, Lyu JR, Lei XM, Li W, Wu G, Lyu J, Dai Z-M. Specific ACE2 expression in small intestinal enterocytes may cause gastrointestinal symptoms and injury after 2019-nCoV infection. Int J Infect Dis. 2020;96:19&#x2013;24. doi:10.1016/j.ijid.2020.04.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.04.027</ArticleId><ArticleId IdType="pmc">PMC7165079</ArticleId><ArticleId IdType="pubmed">32311451</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza MG, Palladini M, Poletti S, Benedetti F. Post-COVID-19 depressive symptoms: epidemiology, pathophysiology, and pharmacological treatment. CNS Drugs. 2022;36(7):681&#x2013;702. doi:10.1007/s40263-022-00931-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40263-022-00931-3</ArticleId><ArticleId IdType="pmc">PMC9210800</ArticleId><ArticleId IdType="pubmed">35727534</ArticleId></ArticleIdList></Reference><Reference><Citation>Sauer MC, Barlow PB, Comellas AP, Garg A. Anxiety and depression symptoms among patients with long COVID: a retrospective cohort study. Eur Archiv Psychiatry and Clin Neurosci. 2024; doi:10.1007/s00406-023-01740-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00406-023-01740-5</ArticleId><ArticleId IdType="pubmed">38231397</ArticleId></ArticleIdList></Reference><Reference><Citation>Radjabzadeh D, Bosch JA, Uitterlinden AG, Zwinderman AH, Ikram MA, van Meurs JBJ, Luik AI, Nieuwdorp M, Lok A, van Duijn CM, et al. Gut microbiome-wide association study of depressive symptoms. Nat Commun. 2022;13(1):7128. doi:10.1038/s41467-022-34502-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-34502-3</ArticleId><ArticleId IdType="pmc">PMC9726982</ArticleId><ArticleId IdType="pubmed">36473852</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashimoto K. Detrimental effects of COVID-19 in the brain and therapeutic options for long COVID: the role of Epstein&#x2013;Barr virus and the gut&#x2013;brain axis. Mol Psychiatry. 2023;28(12):4968&#x2013;4976. doi:10.1038/s41380-023-02161-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-023-02161-5</ArticleId><ArticleId IdType="pmc">PMC11041741</ArticleId><ArticleId IdType="pubmed">37402856</ArticleId></ArticleIdList></Reference><Reference><Citation>Plummer AM, Matos YL, Lin HC, Ryman SG, Birg A, Quinn DK, Parada AN, Vakhtin AA. Gut-brain pathogenesis of post-acute COVID-19 neurocognitive symptoms. Front Neurosci. 2023;17:1232480. doi:10.3389/fnins.2023.1232480.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2023.1232480</ArticleId><ArticleId IdType="pmc">PMC10568482</ArticleId><ArticleId IdType="pubmed">37841680</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Du S, Bimler LH, Mauk KE, Lortal L, Kichik N, Griffiths JS, Osicka R, Song L, Polsky K, et al. Toll-like receptor 4 and CD11b expressed on microglia coordinate eradication of Candida albicans cerebral mycosis. Cell Rep. 2023;42(10):113240. doi:10.1016/j.celrep.2023.113240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2023.113240</ArticleId><ArticleId IdType="pmc">PMC10753853</ArticleId><ArticleId IdType="pubmed">37819761</ArticleId></ArticleIdList></Reference><Reference><Citation>Budden KF, Gellatly SL, Wood DLA, Cooper MA, Morrison M, Hugenholtz P, Hansbro PM. Emerging pathogenic links between microbiota and the gut&#x2013;lung axis. Nat Rev Microbiol. 2017;15(1):55&#x2013;63. doi:10.1038/nrmicro.2016.142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro.2016.142</ArticleId><ArticleId IdType="pubmed">27694885</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer KC, Arend RA, Kalayoglu MV, Rosenthal NS, Byrne GI, Brown RR. Tryptophan metabolism in chronic inflammatory lung disease. J Lab Clin Med. 1995;126:530&#x2013;540.</Citation><ArticleIdList><ArticleId IdType="pubmed">7490512</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho SJ, Hong KS, Schenck E, Lee S, Harris R, Yang J, Choi AMK, Stout-Delgado H. Decreased IDO1-dependent tryptophan metabolism in aged lung during influenza. Eur Respir J. 2021;57(5):2000443. doi:10.1183/13993003.00443-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00443-2020</ArticleId><ArticleId IdType="pmc">PMC8147522</ArticleId><ArticleId IdType="pubmed">33243840</ArticleId></ArticleIdList></Reference><Reference><Citation>Natalini JG, Singh S, Segal LN. The dynamic lung microbiome in health and disease. Nat Rev Microbiol. 2023;21(4):222&#x2013;235. doi:10.1038/s41579-022-00821-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00821-x</ArticleId><ArticleId IdType="pmc">PMC9668228</ArticleId><ArticleId IdType="pubmed">36385637</ArticleId></ArticleIdList></Reference><Reference><Citation>Sencio V, Machado MG, Trottein F. The lung&#x2013;gut axis during viral respiratory infections: the impact of gut dysbiosis on secondary disease outcomes. Mucosal Immunol. 2021;14(2):296&#x2013;304. doi:10.1038/s41385-020-00361-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41385-020-00361-8</ArticleId><ArticleId IdType="pmc">PMC7835650</ArticleId><ArticleId IdType="pubmed">33500564</ArticleId></ArticleIdList></Reference><Reference><Citation>de Oliveira GLV, Oliveira CNS, Pinzan CF, de Salis Lvv, Cardoso CRd B, de Oliveira GLV, de Salis LVV. Microbiota modulation of the Gut-lung Axis in COVID-19. Front Immunol. 2021;12:12. doi:10.3389/fimmu.2021.635471.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.635471</ArticleId><ArticleId IdType="pmc">PMC7945592</ArticleId><ArticleId IdType="pubmed">33717181</ArticleId></ArticleIdList></Reference><Reference><Citation>Vestad B, Ueland T, Lerum TV, Dahl TB, Holm K, Barratt-Due A, K&#xe5;sine T, Dyrhol&#x2010;Riise AM, Stiksrud B, Tonby K, et al. Respiratory dysfunction three months after severe COVID-19 is associated with gut microbiota alterations. J Intern Med. 2022;291(6):801&#x2013;812. doi:10.1111/joim.13458.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13458</ArticleId><ArticleId IdType="pmc">PMC9115297</ArticleId><ArticleId IdType="pubmed">35212063</ArticleId></ArticleIdList></Reference><Reference><Citation>Bulanda E, Wypych TP. Bypassing the gut&#x2013;lung axis via microbial metabolites: implications for chronic respiratory diseases. Front Microbiol. 2022;13. doi:10.3389/fmicb.2022.857418.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2022.857418</ArticleId><ArticleId IdType="pmc">PMC9113535</ArticleId><ArticleId IdType="pubmed">35591998</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie L, Chen L, Li X, Zhou J, Tian H, Zhao J, Li Z, Li Y. Analysis of lung microbiome in COVID-19 patients during time of hospitalization. Pathogens. 2023;12(7):12. doi:10.3390/pathogens12070944.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens12070944</ArticleId><ArticleId IdType="pmc">PMC10386632</ArticleId><ArticleId IdType="pubmed">37513791</ArticleId></ArticleIdList></Reference><Reference><Citation>Corr&#xea;a RO, Castro PR, Moser R, Ferreira CM, Quesniaux VFJ, Vinolo MAR, Ryffel B. Butyrate: connecting the gut-lung axis to the management of pulmonary disorders. Front Nutr. 2022;9. doi:10.3389/fnut.2022.1011732.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2022.1011732</ArticleId><ArticleId IdType="pmc">PMC9631819</ArticleId><ArticleId IdType="pubmed">36337621</ArticleId></ArticleIdList></Reference><Reference><Citation>Enaud R, Prevel R, Ciarlo E, Beaufils F, Wie&#xeb;rs G, Guery B, Delhaes L. The gut-lung axis in health and respiratory diseases: a place for inter-organ and inter-Kingdom Crosstalks. Front Cell Infect Microbiol. 2020;10:9. doi:10.3389/fcimb.2020.00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2020.00009</ArticleId><ArticleId IdType="pmc">PMC7042389</ArticleId><ArticleId IdType="pubmed">32140452</ArticleId></ArticleIdList></Reference><Reference><Citation>Pabst O, Hornef MW, Schaap FG, Cerovic V, Clavel T, Bruns T. Gut&#x2013;liver axis: barriers and functional circuits. Nat Rev Gastroenterol Hepatol. 2023;20(7):447&#x2013;461. doi:10.1038/s41575-023-00771-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41575-023-00771-6</ArticleId><ArticleId IdType="pubmed">37085614</ArticleId></ArticleIdList></Reference><Reference><Citation>Biagini F, Daddi C, Calvigioni M, De Maria C, Zhang YS, Ghelardi E, Vozzi G. Designs and methodologies to recreate in vitro human gut microbiota models. Bio-des Manuf. 2023;6(3):298&#x2013;318. doi:10.1007/s42242-022-00210-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42242-022-00210-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiese M, Schuren FHJ, Smits WK, Kuijper EJ, Ouwens A, Heerikhuisen M, Vigsnaes L, van den Broek TJ, de Boer P, Montijn RC, et al. 2&#x2019;-fucosyllactose inhibits proliferation of clostridioides difficile ATCC 43599 in the CDi-screen, an in vitro model simulating clostridioides difficile infection. Front Cell Infect Microbiol. 2022;12:12. doi:10.3389/fcimb.2022.991150.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.991150</ArticleId><ArticleId IdType="pmc">PMC9650113</ArticleId><ArticleId IdType="pubmed">36389156</ArticleId></ArticleIdList></Reference><Reference><Citation>Brogna C, Brogna B, Bisaccia DR, Lauritano F, Marino G, Montano L, Cristoni S, Prisco M, Piscopo M. Could SARS-CoV-2 have bacteriophage behavior or induce the activity of other bacteriophages? Vaccines (Basel). 2022;10(5):10. doi:10.3390/vaccines10050708.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10050708</ArticleId><ArticleId IdType="pmc">PMC9143435</ArticleId><ArticleId IdType="pubmed">35632464</ArticleId></ArticleIdList></Reference><Reference><Citation>Zupin L, Fontana F, Clemente L, Ruscio M, Ricci G, Crovella S. Effect of short time of SARS-CoV-2 infection in caco-2 cells. Viruses. 2022;14(4):14. doi:10.3390/v14040704.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14040704</ArticleId><ArticleId IdType="pmc">PMC9031642</ArticleId><ArticleId IdType="pubmed">35458434</ArticleId></ArticleIdList></Reference><Reference><Citation>De Souza Ga P, Le Bideau M, Boschi C, Wurtz N, Colson P, Aherfi S, Devaux C, La Scola B. Choosing a cellular model to study SARS-CoV-2. Front Cell Infect Microbiol. 2022;12:12. doi:10.3389/fcimb.2022.1003608.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.1003608</ArticleId><ArticleId IdType="pmc">PMC9634005</ArticleId><ArticleId IdType="pubmed">36339347</ArticleId></ArticleIdList></Reference><Reference><Citation>Deinhardt-Emmer S, B&#xf6;ttcher S, H&#xe4;ring C, Giebeler L, Henke A, Zell R, Jungwirth J, Jordan PM, Werz O, Hornung F, et al. SARS-CoV-2 causes severe epithelial inflammation and barrier dysfunction. J Virol. 2021;95(10). doi:10.1128/JVI.00110-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00110-21</ArticleId><ArticleId IdType="pmc">PMC8139673</ArticleId><ArticleId IdType="pubmed">33637603</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M, Kleine-Weber H, Schroeder S, Kr&#xfc;ger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu N-H, Nitsche A, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271&#x2013;80.e8. doi:10.1016/j.cell.2020.02.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Mar&#xed;n-Palma D, Tabares-Guevara JH, Zapata-Cardona MI, Fl&#xf3;rez-&#xc1;lvarez L, Yepes LM, Rugeles MT, Zapata-Builes W, Hernandez JC, Taborda NA. Curcumin inhibits in vitro SARS-CoV-2 infection in vero E6 cells through multiple antiviral mechanisms. Molecules. 2021;26(22):26. doi:10.3390/molecules26226900.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules26226900</ArticleId><ArticleId IdType="pmc">PMC8618354</ArticleId><ArticleId IdType="pubmed">34833991</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrison DJ, Preston T. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes. 2016;7(3):189&#x2013;200. doi:10.1080/19490976.2015.1134082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2015.1134082</ArticleId><ArticleId IdType="pmc">PMC4939913</ArticleId><ArticleId IdType="pubmed">26963409</ArticleId></ArticleIdList></Reference><Reference><Citation>Gou HZ, Zhang YL, Ren LF, Li ZJ, Zhang L. How do intestinal probiotics restore the intestinal barrier? Front Microbiol. 2022;13:929346. doi:10.3389/fmicb.2022.929346.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2022.929346</ArticleId><ArticleId IdType="pmc">PMC9330398</ArticleId><ArticleId IdType="pubmed">35910620</ArticleId></ArticleIdList></Reference><Reference><Citation>Clausen MR, Mortensen PB. Kinetic studies on colonocyte metabolism of short chain fatty acids and glucose in ulcerative colitis. Gut. 1995;37(5):684. doi:10.1136/gut.37.5.684.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gut.37.5.684</ArticleId><ArticleId IdType="pmc">PMC1382875</ArticleId><ArticleId IdType="pubmed">8549946</ArticleId></ArticleIdList></Reference><Reference><Citation>Paparo L, Maglio MA, Cortese M, Bruno C, Capasso M, Punzo E, Ferrucci V, Lasorsa VA, Viscardi M, Fusco G, et al. A new butyrate releaser exerts a protective action against SARS-CoV-2 infection in human intestine. Molecules. 2022;27(3):27. doi:10.3390/molecules27030862.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules27030862</ArticleId><ArticleId IdType="pmc">PMC8838168</ArticleId><ArticleId IdType="pubmed">35164139</ArticleId></ArticleIdList></Reference><Reference><Citation>Hugenholtz F, de Vos WM. Mouse models for human intestinal microbiota research: a critical evaluation. Cell Mol Life Sci. 2018;75(1):149&#x2013;160. doi:10.1007/s00018-017-2693-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-017-2693-8</ArticleId><ArticleId IdType="pmc">PMC5752736</ArticleId><ArticleId IdType="pubmed">29124307</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan C, Wu Y, Rui X, Yang Y, Ling C, Liu S, Wang, Y. Animal models for COVID-19: advances, gaps and perspectives. Vol. 7. Signal Transduct Target Ther; 2022. p. 220. doi:10.1038/s41392-022-01087-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-01087-8</ArticleId><ArticleId IdType="pmc">PMC9261903</ArticleId><ArticleId IdType="pubmed">35798699</ArticleId></ArticleIdList></Reference><Reference><Citation>Clever S, Volz A. Mouse models in COVID-19 research: analyzing the adaptive immune response. Med Microbiol Immunol. 2023;212(2):165&#x2013;183. doi:10.1007/s00430-022-00735-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00430-022-00735-8</ArticleId><ArticleId IdType="pmc">PMC9166226</ArticleId><ArticleId IdType="pubmed">35661253</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang T, Chakraborty S, Saha P, Mell B, Cheng X, Yeo JY, Mei X, Zhou G, Mandal J, Golonka R, et al. Gnotobiotic rats reveal that gut microbiota regulates colonic mRNA of Ace2, the receptor for SARS-CoV-2 infectivity. Hypertension. 2020;76(1):e1&#x2013;e3. doi:10.1161/HYPERTENSIONAHA.120.15360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.120.15360</ArticleId><ArticleId IdType="pmc">PMC7379164</ArticleId><ArticleId IdType="pubmed">32426999</ArticleId></ArticleIdList></Reference><Reference><Citation>Maiti BK. Bioengineered angiotensin-converting-enzyme-2: a potential therapeutic option against SARS-CoV-2 infection. J Hum Hypertens. 2022;36(5):488&#x2013;492. doi:10.1038/s41371-021-00636-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41371-021-00636-y</ArticleId><ArticleId IdType="pmc">PMC8589099</ArticleId><ArticleId IdType="pubmed">34773078</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu H, Yuan L, Yan Z, Zhou M, Ye J, Wu K, Chen W, Chen R, Xia N, Guan Y, et al. Butyrate protects against SARS-CoV-2-induced tissue damage in golden hamsters. Int J Mol Sci. 2023;24(18):24. doi:10.3390/ijms241814191.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms241814191</ArticleId><ArticleId IdType="pmc">PMC10532055</ArticleId><ArticleId IdType="pubmed">37762492</ArticleId></ArticleIdList></Reference><Reference><Citation>Suresh V, Parida D, Minz AP, Sethi M, Sahoo BS, Senapati S. Tissue distribution of ACE2 protein in Syrian golden hamster (Mesocricetus auratus) and its possible implications in SARS-CoV-2 related studies. Front Pharmacol. 2020;11:579330. doi:10.3389/fphar.2020.579330.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2020.579330</ArticleId><ArticleId IdType="pmc">PMC7869018</ArticleId><ArticleId IdType="pubmed">33568991</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazemian N, Kao D, Pakpour S. Fecal microbiota transplantation during and post-COVID-19 pandemic. Int J Mol Sci. 2021;22(6):22. doi:10.3390/ijms22063004.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22063004</ArticleId><ArticleId IdType="pmc">PMC7998826</ArticleId><ArticleId IdType="pubmed">33809421</ArticleId></ArticleIdList></Reference><Reference><Citation>Park SY, Seo GS. Fecal microbiota transplantation: is it safe? Clin Endosc. 2021;54(2):157&#x2013;160. doi:10.5946/ce.2021.072.</Citation><ArticleIdList><ArticleId IdType="doi">10.5946/ce.2021.072</ArticleId><ArticleId IdType="pmc">PMC8039753</ArticleId><ArticleId IdType="pubmed">33827154</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xe9;nard MV, de Bruijn CMA, Fenneman AC, Wortelboer K, Zeevenhoven J, Rethans B, Herrema HJ, van Gool T, Nieuwdorp M, Benninga MA, et al. Challenges and costs of donor screening for fecal microbiota transplantations. PLOS ONE. 2022;17(10):e0276323. doi:10.1371/journal.pone.0276323.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0276323</ArticleId><ArticleId IdType="pmc">PMC9584411</ArticleId><ArticleId IdType="pubmed">36264933</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H-Y, Zhou D-D, Gan R-Y, Huang S-Y, Zhao C-N, Shang A, Xu X-Y, Li H-B. Effects and mechanisms of probiotics, prebiotics, synbiotics, and postbiotics on metabolic diseases targeting gut microbiota: a narrative review. Nutrients. 2021;13(9):3211. doi:10.3390/nu13093211.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13093211</ArticleId><ArticleId IdType="pmc">PMC8470858</ArticleId><ArticleId IdType="pubmed">34579087</ArticleId></ArticleIdList></Reference><Reference><Citation>Suez J, Zmora N, Segal E, Elinav E. The pros, cons, and many unknowns of probiotics. Nat Med. 2019;25(5):716&#x2013;729. doi:10.1038/s41591-019-0439-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-019-0439-x</ArticleId><ArticleId IdType="pubmed">31061539</ArticleId></ArticleIdList></Reference><Reference><Citation>Xavier-Santos D, Padilha M, Fabiano GA, Vinderola G, Gomes Cruz A, Sivieri K, et al. Evidences and perspectives of the use of probiotics, prebiotics, synbiotics, and postbiotics as adjuvants for prevention and treatment of COVID-19: a bibliometric analysis and systematic review. Trends In Food Sciamp; Technol. 2022;120:174&#x2013;192. doi:10.1016/j.tifs.2021.12.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tifs.2021.12.033</ArticleId><ArticleId IdType="pmc">PMC8720301</ArticleId><ArticleId IdType="pubmed">35002079</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau RI, Su Q, Lau ISF, Ching JYL, Wong MCS, Lau LHS, Tun HM, Mok CKP, Chau SWH, Tse YK, et al. A synbiotic preparation (SIM01) for post-acute COVID-19 syndrome in Hong Kong (RECOVERY): a randomised, double-blind, placebo-controlled trial. The Lancet Infect Dis. 2024;24(3):256&#x2013;265. doi:10.1016/S1473-3099(23)00685-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(23)00685-0</ArticleId><ArticleId IdType="pubmed">38071990</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang H, Cai M, Shen B, Wang Q, Zhang T, Zhou X. Synbiotics and gut microbiota: new perspectives in the treatment of type 2 diabetes mellitus. Foods. 2022;11(16):11. doi:10.3390/foods11162438.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/foods11162438</ArticleId><ArticleId IdType="pmc">PMC9407597</ArticleId><ArticleId IdType="pubmed">36010438</ArticleId></ArticleIdList></Reference><Reference><Citation>Chlebicz-W&#xf3;jcik A, Probiotics &#x15a;K. Prebiotics, and synbiotics in the irritable bowel syndrome treatment: a review. Biomolecules. 2021;11(8):11. doi:10.3390/biom11081154.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom11081154</ArticleId><ArticleId IdType="pmc">PMC8412098</ArticleId><ArticleId IdType="pubmed">34439821</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>